SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-21-006352
Filing Date
2021-01-21
Accepted
2021-01-21 17:22:17
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm213802d1_s3.htm S-3 270045
2 EXHIBIT 5.1 tm213802d1_ex5-1.htm EX-5.1 9534
3 EXHIBIT 23.1 tm213802d1_ex23-1.htm EX-23.1 2972
4 GRAPHIC tm213802d1_s3img001.jpg GRAPHIC 29328
5 GRAPHIC tm213802d1_ex23-1img001.jpg GRAPHIC 5122
6 GRAPHIC tm213802d1_ex23-1img002.jpg GRAPHIC 3500
  Complete submission text file 0001104659-21-006352.txt   336442
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-252309 | Film No.: 21542980
SIC: 2834 Pharmaceutical Preparations